within Pharmacolibrary.Drugs.ATC.B;

model B02BX01
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 2.1 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 500 / 1000000,
    adminCount     = 1,
    Vd             = 0.0002,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Etamsylate is a synthetic hemostatic agent used to reduce blood loss in conditions of capillary fragility or abnormal bleeding. It is most often used to manage perioperative bleeding, heavy menstrual bleeding, and sometimes in the treatment of intracranial hemorrhage. It is not universally approved worldwide but is still in use in various countries, although its efficacy is debated in some indications.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated for a typical adult after intravenous administration based on limited published data and secondary pharmacological sources.</p><h4>References</h4><ol><li><p>Paine, SW, et al., &amp; Hincks, PR (2023). Novel holistic pharmacokinetic model applied to plasma and urine concentrations of 2,5-dihydroxybenzene sulphonate following administrations of calcium dobesilate and etamsylate to exercised horses. <i>Journal of veterinary pharmacology and therapeutics</i> 46(6) 365–374. DOI:<a href=&quot;https://doi.org/10.1111/jvp.13387&quot;>10.1111/jvp.13387</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/37255256/&quot;>https://pubmed.ncbi.nlm.nih.gov/37255256</a></p></li><li><p>Mukherjee, S, et al., &amp; Datta, P (2024). Spatiotemporally Controlled Release of Etamsylate from Bioinspired Peptide-Functionalized Nanoparticles Arrests Bleeding Rapidly and Improves Clot Stability in a Rabbit Internal Hemorrhage Model. <i>ACS biomaterials science &amp; engineering</i> 10(8) 5014–5026. DOI:<a href=&quot;https://doi.org/10.1021/acsbiomaterials.4c00743&quot;>10.1021/acsbiomaterials.4c00743</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/38982893/&quot;>https://pubmed.ncbi.nlm.nih.gov/38982893</a></p></li><li><p>Hannaert, P, et al., &amp; Garay, RP (2003). Vascular permeabilization by intravenous arachidonate in the rat peritoneal cavity: antagonism by ethamsylate. <i>European journal of pharmacology</i> 466(1-2) 207–212. DOI:<a href=&quot;https://doi.org/10.1016/s0014-2999(03)01545-0&quot;>10.1016/s0014-2999(03)01545-0</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/12679158/&quot;>https://pubmed.ncbi.nlm.nih.gov/12679158</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end B02BX01;
